Join us
> News > Astellas and University of Tokyo extend partnership to develop therapies

News & Views

Astellas and University of Tokyo extend partnership to develop therapies
05 May 2022
Public

New projects will use the scientific research of the University of Tokyo with Astellas’ drug discovery expertise.
Astellas Pharma has entered the second phase of a collaboration with the University of Tokyo for jointly developing new therapies and medical solutions.

The partnership is named the Astellas Alliance Acceleration Program (AAAP). 

In the initial phase that lasted from September 2020 to March this year, AAAP created a foundation for the alliance at the university’s Institute for Life Science Research and Education and the University of Tokyo Center of Innovation. 

View more at https://www.pharmaceutical-technology.com/news/astellas-partnership-new-therapies/?fbclid=IwAR0uVo1plwoyEK1O8DKa8W1F-D1YiHSasuOfVfFVdGKZlAJL75ZpcbzhjkQ

Source:  Pharmaceutical-technology

 

How to join Oxentt ?

To join the exclusive Business Agency elite group does not require important financial contribution. It is, however, imperative that by joining all members adhere to its philosophy of ethics, respect and seriousness.

Any business owner from any country, investor, entrepreneur and corporate executives are welcome to join us.

Watch how the Members’ interface Works

Dive into the world of Oxentt and discover how easy and direct is the way to reach out, communicate and cooperate with other members in your own city or throughout the world, online or in real life.
A dozen of features help you invite fellow members or all followers of Oxentt to any event you organize.
Receive a daily digest of international economic and business news dedicated to your own industry or any other industries by geographic area or globally.
Create your own group by area or by business sector and organize online or offline reunions.
Use text messaging or voice and video calls, one-to-one or by group, 100% secured.